Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
SPL Announcements
FDA confirms path to DEP HER2…
SPL
STARPHARMA HOLDINGS LIMITED
Market sensitive
FDA confirms path to DEP HER2 first-in-human study
Date and time
21 April 2026 at 7:40 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
SPL announcement history
Recent SPL announcements
Ceasing to be a substantial holder
Change in substantial holding
Change in substantial holding
Change of Director Interest Notice - R Basser
Change of Director Interest Notice - R Thomas
Change of Director Interest Notice - L Cheng